NGENLA

Pfizer Inc.

Application Filed: 2015-08-20
Trademark Application Details
Trademark Logo NGENLA

Mark For: NGENLA® trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of endocrine diseases and disorders, namely, human growth hormones. [all]

Status

2021-09-20 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number86730692
Registration Number5692027
Mark Literal ElementsNGENLA
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2019-01-28
Basis1(a)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseYes
Intent To UseNo
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameSeana Smith
Attorney Docket NumberT 407889
Law Office AssignedM30
Employee NameMARTIN, LIEF ANDREW

Timeline

2015-08-20Application Filed
2015-12-08Published
2015-12-08Published for Opposition
2019-01-14Date of First Use
2019-01-14Date of Use In Commerce
2019-01-28Location: PUBLICATION AND ISSUE SECTION
2019-03-05Status: Live/Registered
2019-03-05Status: Registered. The registration date is used to determine when post-registration maintenance documents are due.
2019-03-05Trademark Registered
2019-03-05Transaction Date
2024-03-05Maintenance Early File Date
2025-03-05Maintenance On Time Date
2025-09-05Maintenance Late Fee Date

Trademark Parties (Applicants & Owners)

Party: Pfizer Inc.
Address235 East 42nd Street New York, NEW YORK UNITED STATES 10017
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

DrawingJPEG2015-08-20
TEAS Plus New ApplicationMULTI2015-08-20
Notation to FileXML2015-10-30
XSearch Search SummaryXML2015-10-30
TRAM Snapshot of App at Pub for OppostnMULTI2015-11-02
Notice of PublicationXML2015-11-18
Notification Of Notice of PublicationXML2015-11-18
OG Publication ConfirmationXML2015-12-08
Notice of AllowanceXML2016-02-02
Extension of Time to File SOUXML2016-07-14
ITU Extension ApprovalXML2016-07-16
ITU Unit ActionMULTI2016-07-16
Extension of Time to File SOUXML2016-12-15
ITU Extension ApprovalXML2016-12-17
ITU Unit ActionMULTI2016-12-17
Extension of Time to File SOUXML2017-06-21
ITU Extension ApprovalXML2017-06-23
ITU Unit ActionMULTI2017-06-23
Extension of Time to File SOUXML2018-01-18
ITU Extension ApprovalXML2018-01-20
ITU Unit ActionMULTI2018-01-20
Extension of Time to File SOUMULTI2018-05-22
ITU Extension ApprovalXML2018-05-31
ITU Unit ActionMULTI2018-05-31
SpecimenJPEG2019-01-22
Statement of UseMULTI2019-01-22
ITU Unit ActionMULTI2019-01-26
Notice of Acceptance of Statement of UseXML2019-01-29
TRAM Snapshot of App at Pub for OppostnMULTI2019-01-29
Registration CertificatePDF2019-03-05
Change Address or Representation FormXML2020-03-23
Change Address or Representation FormXML2020-03-26

Attorney of Record

SEANA SMITH
Pfizer Inc
235 E 42nd St
New York, NY 10017-5703

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of endocrine diseases and disorders, namely, human growth hormones. FIRST USE: 20190114. FIRST USE IN COMMERCE: 20190114

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations for the treatment of endocrine diseases and disorders, namely, human growth hormones
GS0051Pharmaceutical preparations for the treatment of endocrine diseases and disorders, namely, human growth hormones

Trademark Filing History

DescriptionDateProceeding Number
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED2020-05-2759377
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS2020-03-26
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2020-03-26
TEAS CHANGE OF OWNER ADDRESS RECEIVED2020-03-26
TEAS CHANGE OF CORRESPONDENCE RECEIVED2020-03-26
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2020-03-26
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2020-03-2688888
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS2020-03-23
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2020-03-23
TEAS CHANGE OF OWNER ADDRESS RECEIVED2020-03-23
TEAS CHANGE OF CORRESPONDENCE RECEIVED2020-03-23
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2020-03-23
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2020-03-2388888
REGISTERED-PRINCIPAL REGISTER2019-03-05
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED2019-01-29
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2019-01-28
STATEMENT OF USE PROCESSING COMPLETE2019-01-2574055
USE AMENDMENT FILED2019-01-2274055
TEAS STATEMENT OF USE RECEIVED2019-01-22
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2018-05-31
EXTENSION 5 GRANTED2018-05-3074055
CASE ASSIGNED TO INTENT TO USE PARALEGAL2018-05-3074055
TEAS EXTENSION RECEIVED2018-05-22
EXTENSION 5 FILED2018-05-2274055
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2018-01-20
TEAS EXTENSION RECEIVED2018-01-18
EXTENSION 4 GRANTED2018-01-1898765
EXTENSION 4 FILED2018-01-1898765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2017-06-23
TEAS EXTENSION RECEIVED2017-06-21
EXTENSION 3 GRANTED2017-06-2198765
EXTENSION 3 FILED2017-06-2198765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2016-12-17
TEAS EXTENSION RECEIVED2016-12-15
EXTENSION 2 GRANTED2016-12-1598765
EXTENSION 2 FILED2016-12-1598765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2016-07-16
TEAS EXTENSION RECEIVED2016-07-14
EXTENSION 1 GRANTED2016-07-1498765
EXTENSION 1 FILED2016-07-1498765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2016-02-02
PUBLISHED FOR OPPOSITION2015-12-08
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2015-12-08
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2015-11-18
ASSIGNED TO EXAMINER2015-10-3085328
APPROVED FOR PUB - PRINCIPAL REGISTER2015-10-30
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2015-08-25
NEW APPLICATION ENTERED IN TRAM2015-08-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed